Table 1.

Characteristics of MDT-TB patients compared with TB patients and healthy controls

	Healthy Control (N = 11)	TB (N = 11)	MDR-TB (N = 11)	P Value
Age, age range (Mean ± SD)	45.36 ± 17.85	47.55 ± 17.44	51.27 ± 13.72	0.7856 a
Gender: female, no. (%)	5(45.45)	5(45.45)	3(27.27)	0.8801 b
Positive sputum smears, no. (%)	ND	7(63.64)	6(54.55)	/
Positive sputum culture, no. (%)	ND	4(36.36)	6(54.55)	/
Resistant to INH by DST, no. (%)	ND	0(0)	11(100)	/
Resistant to RFP by DST, no. (%)	ND	0(0)	11(100)	/
TC (mmol/L)	4.45 ± 1.02	4.18 ± 1.07	4.04 ± 0.93	0.5982 a
TG (mmol/L)	1.02 ± 0.28	1.10 ± 0.63	0.99 ± 0.23	0.5703 a
HDL (mmol/L)	1.36 ± 0.15	1.26 ± 0.14	1.36 ± 0.16	0.1989 a
LDL (mmol/L)	2.68 ± 0.49	2.81 ± 0.43	2.72 ± 0.34	0.8186

DST Drug susceptibility testing, INH Isoniazide, RFP Rifampicin, TC Total cholesterol, TG Triglyceride, HDL High-density lipoprotein, LDL Low-density lipoprotein, N number of subjects, ND Not determined

^a P-value for Kruskal-Wallis test, ^b P-value for chi-square test

*P < 0.05. **P < 0.01. *** P < 0.001